Hepatitis C Direct Acting Antiviral Therapies in a New York City HIV/AIDS Special Needs Plan: Uptake and Barriers
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
AIDS patient care and STDs - 29(2015), 12, Seite 643-645 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kuniholm, Mark H [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1089/apc.2015.0240 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1957947780 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1957947780 | ||
| 003 | DE-627 | ||
| 005 | 20230518003406.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1089/apc.2015.0240 |2 doi | |
| 028 | 5 | 2 | |a PQ20160430 |
| 035 | |a (DE-627)OLC1957947780 | ||
| 035 | |a (DE-599)GBVOLC1957947780 | ||
| 035 | |a (PRQ)m1273-f7e59d1728d8aa657ad7f5c79ea4040fb052fd31f2268faa76be0e0a2d5105fe0 | ||
| 035 | |a (KEY)0165206020150000029001200643hepatitiscdirectactingantiviraltherapiesinanewyork | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Kuniholm, Mark H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatitis C Direct Acting Antiviral Therapies in a New York City HIV/AIDS Special Needs Plan: Uptake and Barriers |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Medicaid - statistics & numerical data | |
| 650 | 4 | |a Antiviral Agents - administration & dosage | |
| 650 | 4 | |a HIV Infections - virology | |
| 650 | 4 | |a Antiviral Agents - therapeutic use | |
| 650 | 4 | |a Sofosbuvir - administration & dosage | |
| 650 | 4 | |a Hepatitis C - diagnosis | |
| 650 | 4 | |a HIV Infections - drug therapy | |
| 650 | 4 | |a Hepatitis C - drug therapy | |
| 700 | 1 | |a Leach, Terry |4 oth | |
| 700 | 1 | |a Lunievicz, Joseph |4 oth | |
| 700 | 1 | |a Olivo, Noemí |4 oth | |
| 700 | 1 | |a Anastos, Kathryn |4 oth | |
| 700 | 1 | |a Vazquez, Yvette |4 oth | |
| 700 | 1 | |a Brennan-Ing, Mark |4 oth | |
| 700 | 1 | |a Karpiak, Stephen E |4 oth | |
| 700 | 1 | |a Alao, Oladipo |4 oth | |
| 700 | 1 | |a Nash, Denis |4 oth | |
| 700 | 1 | |a Ernst, Jerome |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t AIDS patient care and STDs |d Larchmont, NY : Liebert, 1996 |g 29(2015), 12, Seite 643-645 |w (DE-627)214080811 |w (DE-600)1326868-5 |x 1087-2914 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2015 |g number:12 |g pages:643-645 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1089/apc.2015.0240 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26669792 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2015 |e 12 |h 643-645 | ||